Board decisions place country ownership at the heart of a new operating model, reflecting key elements of the Gavi Leap transformation agenda.

The Boards of Gavi, the Vaccine Alliance (Gavi) and the Global Polio Eradication Initiative (GPEI) convened to further strengthen collaboration and accelerate progress toward shared goals: reaching zero-dose and under-immunized children with…

Morocco makes a donation to Gavi, pledging US$ 5 million towards its next strategic period.

A new report from the World Health Organization (WHO) underscores the remarkable progress made in the fight against measles over the past 24 years.

Ethiopia has launched the national introduction of the HepB BD vaccine, marking a major step in strengthening newborn immunization and combating the transmission of Hepatitis B virus. 

Deal secures more accessible future price per dose, resulting savings of up to US$ 90 million. Savings expected to help secure 30 million additional doses, protecting up to 7 million more children with malaria vaccine.

The Government of Pakistan’s FDI – in partnership with Gavi, UNICEF, and the WHO – launched a national measles and rubella (MR) vaccination campaign in Islamabad today to protect 34.6 million children.

Major push by Gavi, the Vaccine Alliance and lower-income countries to extend access to the HPV vaccine has reached its target ahead of schedule.

Brazil commits US$ 72 million to Gavi’s 2026–2030 strategic period, reinforcing its role as a key stakeholder in global health and vaccine manufacturing.